Skip to main content

Advertisement

SpringerLink
Log in

Amyloid-β, vitamin D: why we should triangulate conclusions about therapeutic targets in Alzheimer’s disease

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Munafò MR, Davey SG (2018) Robust research needs many lines of evidence. Nature 553(7689):399–401. https://doi.org/10.1038/d41586-018-01023-3

    Article  CAS  PubMed  Google Scholar 

  2. Daly T et al (2020) Amyloid-β in Alzheimer’s disease: a study of citation practices of the amyloid cascade hypothesis between 1992 and 2019. J Alzheimers Dis 74(4):1309–1317. https://doi.org/10.3233/JAD-191321

    Article  PubMed  Google Scholar 

  3. Gregory S, Saunders S, Ritchie CW (2022) Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer’s disease. Lancet Healthy Longev 3(11):e797–e803. https://doi.org/10.1016/S2666-7568(22)00219-7

    Article  PubMed  Google Scholar 

  4. Lai RH et al (2022) Vitamin D supplementation worsens Alzheimer’s progression: animal model and human cohort studies. Aging Cell 21(8):e13670. https://doi.org/10.1111/acel.13670

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Cummings J, Feldman HH, Scheltens P (2019) The, “rights” of precision drug development for Alzheimer’s disease. Alzheimers Res Ther 11(1):76. https://doi.org/10.1186/s13195-019-0529-5

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Thanks to an anonymous reviewer for helpful comments and suggestions.

Author information

Authors and Affiliations

  1. Science Norms Democracy UMR 8011, Sorbonne Université, Paris, France

    Timothy Daly

  2. Bioethics Program, FLACSO Argentina, Buenos Aires, Argentina

    Timothy Daly

Authors
  1. Timothy Daly
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The author contributed to all parts of the study analysis, development, and interpretation.

Corresponding author

Correspondence to Timothy Daly.

Ethics declarations

Ethical approval

Not applicable.

Informed consent

Not applicable.

Conflict of interest

The author declares no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Daly, T. Amyloid-β, vitamin D: why we should triangulate conclusions about therapeutic targets in Alzheimer’s disease. Neurol Sci 44, 3321–3322 (2023). https://doi.org/10.1007/s10072-023-06840-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06840-7

Search

Navigation